Search details
1.
MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase.
Brain
; 144(9): 2722-2731, 2021 10 22.
Article
in English
| MEDLINE | ID: mdl-34581780
2.
Spinal muscular atrophy care in the COVID-19 pandemic era.
Muscle Nerve
; 62(1): 46-49, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32329921
3.
Thoracoscopic thymectomy for juvenile myasthenia gravis.
Pediatr Surg Int
; 35(5): 603-610, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30729982
4.
Dystrophinopathies.
Semin Neurol
; 35(4): 369-84, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26502761
5.
Subspecialty Health Care Utilization in Pediatric Patients With Muscular Dystrophy in the United States.
Neurol Clin Pract
; 14(4): e200312, 2024 Aug.
Article
in English
| MEDLINE | ID: mdl-38855715
6.
Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study.
Pediatr Neurol
; 156: 198-207, 2024 Apr 26.
Article
in English
| MEDLINE | ID: mdl-38810600
7.
Clinical importance of changes in magnetic resonance biomarkers for Duchenne muscular dystrophy.
Ann Clin Transl Neurol
; 11(1): 67-78, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37932907
8.
Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy.
J Neuromuscul Dis
; 10(4): 685-699, 2023.
Article
in English
| MEDLINE | ID: mdl-37248912
9.
Intrathecal Onasemnogene Abeparvovec for Sitting, Nonambulatory Patients with Spinal Muscular Atrophy: Phase I Ascending-Dose Study (STRONG).
J Neuromuscul Dis
; 10(3): 389-404, 2023.
Article
in English
| MEDLINE | ID: mdl-36911944
10.
Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States.
J Am Heart Assoc
; 11(8): e024722, 2022 04 19.
Article
in English
| MEDLINE | ID: mdl-35411787
11.
Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial.
PLoS One
; 17(8): e0272858, 2022.
Article
in English
| MEDLINE | ID: mdl-35998119
12.
Quantitative magnetic resonance imaging measures as biomarkers of disease progression in boys with Duchenne muscular dystrophy: a phase 2 trial of domagrozumab.
J Neurol
; 269(8): 4421-4435, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-35396602
13.
Diagnostic Testing for Patients with Spinal Muscular Atrophy.
Clin Lab Med
; 40(3): 357-367, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32718505
14.
Retrospective Analysis of Fractures and Factors Causing Ambulation Loss After Lower Limb Fractures in Duchenne Muscular Dystrophy.
Am J Phys Med Rehabil
; 99(9): 789-794, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32195737
15.
Ethical Challenges Confronted When Providing Nusinersen Treatment for Spinal Muscular Atrophy.
JAMA Pediatr
; 172(2): 188-192, 2018 Feb 01.
Article
in English
| MEDLINE | ID: mdl-29228163
16.
Spinal muscular atrophy: Further expanding the clinician's armamentarium.
Neurology
; 93(14): 613-614, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-31488614
17.
Intermediate-dose idebenone and quality of life in Friedreich ataxia.
Pediatr Neurol
; 42(5): 338-42, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20399388
18.
Cerebral arteriopathy in children with neurofibromatosis type 1.
Pediatrics
; 124(3): e476-83, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19706560
Results
1 -
18
de 18
1
Next >
>>